Medical Affairs play an important function which
is required for development and commercialization of medicines between
patients, healthcare professionals and healthcare industry. Its professionals
usually have responsibility for the following general areas include ensuring
that their industries comply with all of the regulations and laws, and working
with local, state and federal regulatory agencies such as the Food and Drug
Administration or European Medicines Agency on specific issues affecting their
business. Obtaining a new medicine to market is a unique process based on a
number of requirements for supporting a product launch. New antibody drug conjugate treatments are used these days.
Management of Medical Affairs provides the
quality clinical data by ensuring the adherence to SOPs and GCP under ICH
recommendation guidelines and maintains the ICH-GCP compliance. Generally,
Pharmaceutical industries have two types of scientific teams, one of Medical
Affairs services and another for research and development. Research and
development describes the initial stage of development and scientific method,
as well as includes clinical trial runs, while its services provide scientific
support for the end stage of development and post marketing.
A function of its services includes delivering
technical backing to internal teams as well as external consumers, and
field-based medical information specialists who provide in-depth drug and
disease information to health providers. Its services deliver information to
ensure that consumer queries are adequately addressed and distribute data to
health care providers in the community. Its team also frame plans, review,
publications and report of important clinical trial results to the
Pharmaceuticals and medical devices agency (PMDA), in scientific meetings or by
providing journal articles etc.
Department of research and development of
industry, may look to be an issue for someone else to handle in the far-distant
future and at a much later time from launching a product into the market but
even at laboratory or early development stages, biotechnology industries should
understand the language of pharmaceutical industries and know how that industry
operates and make early decisions regarding their investigations products that
could lead to future success.
Global Allied Pharmaceuticals (GAP) has industry
trained specialists in Medical Oncology.
In biotechnology, there is no real equivalent to medical affairs; still
it plays an important role in the pharmaceutical industry that highlights its
importance both in pre launch and during the launch of new medicine. We provide
several services include Product Development & Commercialization, Market
Access, Regulatory & Quality and Market Intelligence.
For more information,
contact us at www.gapsos.com
No comments:
Post a Comment